Axa S.A. Precigen, Inc. Transaction History

Axa S.A.

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$0.96 - $1.4 $29,760 - $43,400	31,000 New	31,000 $35,000
Q3 2022 Feb 14, 2023	BUY	$1.41 - $2.79 $546,657 - $1.08 Million	387,700 Added 1582.45%	412,200 $873,000
Q3 2022 Nov 14, 2022	BUY	$1.41 - $2.79 $546,657 - $1.08 Million	387,700 Added 1582.45%	412,200 $874,000
Q2 2022 Feb 14, 2023	SELL	$1.15 - $2.53 $505,309 - $1.11 Million	-439,400 Reduced 94.72%	24,500 $32,000
Q2 2022 Aug 15, 2022	SELL	$1.15 - $2.53 $505,309 - $1.11 Million	-439,400 Reduced 94.72%	24,500 $33,000
Q1 2022 Feb 14, 2023	BUY	$1.91 - $3.98 $98,747 - $205,766	51,700 Added 12.54%	463,900 $978,000
Q1 2022 May 13, 2022	BUY	$1.91 - $3.98 $766,483 - $1.6 Million	401,300 Added 641.05%	463,900 $979,000
Q4 2021 Feb 14, 2022	BUY	$3.53 - $5.5 $161,321 - $251,350	45,700 Added 270.41%	62,600 $232,000
Q3 2021 Nov 15, 2021	BUY	$4.99 - $6.55 $84,331 - $110,695	16,900 New	16,900 $84,000
Q4 2020 Feb 12, 2021	SELL	$3.75 - $10.56 $1.15 Million - $3.23 Million	-305,400 Closed	0 $0
Q3 2020 Nov 13, 2020	SELL	$3.5 - $6.2 $467,978 - $828,989	-133,708 Reduced 30.45%	305,400 $1.07 Million
Q1 2020 May 15, 2020	BUY	$1.46 - $7.19 $641,097 - $3.16 Million	439,108 New	439,108 $1.49 Million

143

161M

232K

69K

Ticker PGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 208,150,000
Market Cap $354M
Description
Precigen, Inc. discovers and develops the next generation of gene and cellular therapies in the United States. It also provides disease-modifying therapeutics; genetically engineered swine for regenerative medicine applications; and reproductive and embryo transfer technologies. In addition, the company offers UltraVector platform that incorpora...

Get notified when there are updates to the investment portfolio of Axa S.A., based on Form 13F filings with the SEC.

Stay updated on Axa S.A. with notifications on news.